Related Experiment Video
Updated: Jan 9, 2026

14:26
Genome-wide Purification of Extrachromosomal Circular DNA from Eukaryotic Cells
Published on: April 4, 2016
25.8K
scCirclehunter delineates ecDNA-containing cells using single-cell ATAC-seq, with a focus on glioblastoma
Rong Jiang1, Zhengmao Lu2, Fang Li1
1MOE Key Laboratory of Geriatric Diseases and Immunology, School of Basic Medical Sciences, Soochow University, Suzhou, Jiangsu, China.
Cell Discovery
|December 8, 2025
Summary
Extrachromosomal DNA (ecDNA) drives cancer heterogeneity and poor prognosis. Our new scCirclehunter tool analyzes patient ecDNA at single-cell resolution, revealing its role in glioblastoma progression and cell evolution.
Area of Science:
- Genomics
- Cancer Biology
- Single-cell analysis
Background:
- Extrachromosomal DNA (ecDNA) is a key driver of tumor heterogeneity and poor prognosis in cancer.
- Limited single-cell resolution studies exist for patient-derived ecDNA.
Purpose of the Study:
- Introduce scCirclehunter, a novel framework to identify ecDNA from single-cell ATAC-seq (scATAC-seq) data.
- Analyze ecDNA heterogeneity and cellular trajectories in glioblastoma (GBM) patients.
- Investigate mechanisms of ecDNA-driven tumor progression and potential links to mitochondrial transfer.
Main Methods:
- Developed scCirclehunter for ecDNA identification and cell population assignment from scATAC-seq data.
- Applied scCirclehunter to glioblastoma datasets.
- Integrated scRNA-seq data for mechanistic insights and analysis of ecNR2E1.
- Examined intercellular heterogeneity and cell trajectories.
Main Results:
- Uncovered significant inter-cellular heterogeneity of ecDNA-carrying cells across GBM patients.
- Traced malignant cell trajectories in patients with multiple ecDNAs.
- Demonstrated ecDNA drives GBM progression via multiple mechanisms, exemplified by ecNR2E1.
- Observed a potential link between ecDNA and increased mitochondrial transfer frequency.
Conclusions:
- scCirclehunter offers a powerful framework for single-cell precision analysis of patient-specific ecDNAs.
- Provides critical insights into the role of ecDNA-carrying cells in driving GBM heterogeneity.
- Highlights ecDNA as a significant factor in glioblastoma pathogenesis and progression.

